As of June 16, 2025, Compumedics Ltd (CMP.AX) reports a Gross Margin of 52.43%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of Compumedics Ltd's Gross Margin
Over recent years, Compumedics Ltd's Gross Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2024-06-30 | 52.43% |
| 2023-06-30 | 50.91% |
| 2022-06-30 | 51.17% |
| 2021-06-30 | 53.62% |
| 2020-06-30 | 51.36% |
This slight upward trend highlights how Compumedics Ltd manages its operational efficiency and pricing power over time.
Comparing Compumedics Ltd's Gross Margin to Peers
To better understand Compumedics Ltd's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| Compumedics Ltd (CMP.AX) | 52.43% |
| Simavita Ltd (SVA.AX) | 5584.01% |
| EMvision Medical Devices Ltd (EMV.AX) | 100.14% |
| Neurotech International Ltd (NTI.AX) | 100.00% |
| Vitasora Health Ltd (RSH.AX) | 99.63% |
| Analytica Ltd (ALT.AX) | 97.00% |
Compared to its competitors, Compumedics Ltd's Gross Margin is about average compared to peers, indicating industry-standard operational efficiency.